Elecsys Afp
by Roche Diagnostics GmbH Germany 510(k)
510(k) K981282
Product code LOJ
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK981282 | Date1 May 1998 | StatusActive |
Coverage
- Active
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LOJ
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.6010
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent
From the manufacturer
Roche cannot respond to questions about general medical information or questions regarding your personal medical condition. Please do not use this form to report complaints or adverse events, or to ask any questions regarding medical products.
A prospective multicenter study (Roche study No. RD002542 and RD002543) to evaluate the clinical performance of Elecsys AFP as an aid in the diagnosis of HCC included 376 patients with liver disease, of which 168 had HCC and 208 had liver disease but no diagnosis of HCC (control).
Other devices from Roche Diagnostics GmbH
Properties & raw data
Show properties, registry sources and raw records
Sources (1)
- FDA 510(k) K981282